Cargando…

Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products

Cannabinoid receptors (CB1 and CB2), as part of the endocannabinoid system, play a critical role in numerous human physiological and pathological conditions. Thus, considerable efforts have been made to develop ligands for CB1 and CB2, resulting in hundreds of phyto- and synthetic cannabinoids which...

Descripción completa

Detalles Bibliográficos
Autores principales:	An, Dongchen, Peigneur, Steve, Hendrickx, Louise Antonia, Tytgat, Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404216/ https://www.ncbi.nlm.nih.gov/pubmed/32709050 http://dx.doi.org/10.3390/ijms21145064

Ejemplares similares

WIN55,212-2, a Dual Modulator of Cannabinoid Receptors and G Protein-Coupled Inward Rectifier Potassium Channels
por: An, Dongchen, et al.
Publicado: (2021)

Conotoxins Targeting Nicotinic Acetylcholine Receptors: An Overview
por: Lebbe, Eline K. M., et al.
Publicado: (2014)

Cannabinoids in the Treatment of Epilepsy: Current Status and Future Prospects
por: Morano, Alessandra, et al.
Publicado: (2020)

Caterpillar Venom: A Health Hazard of the 21st Century
por: Seldeslachts, Andrea, et al.
Publicado: (2020)

Current Status and Future Prospects of Marine Natural Products (MNPs) as Antimicrobials
por: Choudhary, Alka, et al.
Publicado: (2017)

Discovery of K(V)1.3 ion channel inhibitors: Medicinal chemistry approaches and challenges
por: Gubič, Špela, et al.
Publicado: (2021)

Toxins in Drug Discovery and Pharmacology
por: Peigneur, Steve, et al.
Publicado: (2018)

Cannabinoids as anticancer drugs: current status of preclinical research
por: Hinz, Burkhard, et al.
Publicado: (2022)

Cannabinoids as therapeutic agents in cancer: current status and future implications
por: Chakravarti, Bandana, et al.
Publicado: (2014)

AsKC11, a Kunitz Peptide from Anemonia sulcata, Is a Novel Activator of G Protein-Coupled Inward-Rectifier Potassium Channels
por: An, Dongchen, et al.
Publicado: (2022)

Nanoparticle Delivery of Natural Products in the Prevention and Treatment of Cancers: Current Status and Future Prospects
por: Bharali, Dhruba J., et al.
Publicado: (2011)

Venomous Secretions from Marine Snails of the Terebridae Family Target Acetylcholine Receptors
por: Kendel, Yvonne, et al.
Publicado: (2013)

Neurotoxins and Their Binding Areas on Voltage-Gated Sodium Channels
por: Stevens, Marijke, et al.
Publicado: (2011)

Cannabinoids and Cannabinoid Receptors: The Story so Far
por: Shahbazi, Fred, et al.
Publicado: (2020)

New Diarylamine K(V)10.1 Inhibitors and Their Anticancer Potential
por: Gubič, Špela, et al.
Publicado: (2022)

“The Cannabinoid Receptors”
por: Reznicek, Gottfried
Publicado: (2010)

Review: HCN Channels in the Heart
por: Depuydt, Anne-Sophie, et al.
Publicado: (2022)

Allosteric Modulation of Cannabinoid Receptor 1—Current Challenges and Future Opportunities
por: Hryhorowicz, Szymon, et al.
Publicado: (2019)

Current Status and Prospects of Targeted Therapy for Osteosarcoma
por: Hu, Zunguo, et al.
Publicado: (2022)

3D Pharmacophore-Based Discovery of Novel K(V)10.1 Inhibitors with Antiproliferative Activity
por: Toplak, Žan, et al.
Publicado: (2021)

Biosynthesis of Nature-Inspired Unnatural Cannabinoids
por: Lim, Kevin J. H., et al.
Publicado: (2021)

Unraveling the venom chemistry with evidence for histamine as key regulator in the envenomation by caterpillar Automeris zaruma
por: Seldeslachts, Andrea, et al.
Publicado: (2022)

Natural Products as Anticancer Agents: Current Status and Future Perspectives
por: Naeem, Abid, et al.
Publicado: (2022)

The Natural Product Magnolol as a Lead Structure for the Development of Potent Cannabinoid Receptor Agonists
por: Fuchs, Alexander, et al.
Publicado: (2013)

Cannabinoids and Their Receptors in Skin Diseases
por: Yoo, Eun Hee, et al.
Publicado: (2023)

Targeting Peripherally Restricted Cannabinoid Receptor 1, Cannabinoid Receptor 2, and Endocannabinoid-Degrading Enzymes for the Treatment of Neuropathic Pain Including Neuropathic Orofacial Pain
por: Hossain, Mohammad Zakir, et al.
Publicado: (2020)

The Skin and Natural Cannabinoids–Topical and Transdermal Applications
por: Filipiuc, Silviu-Iulian, et al.
Publicado: (2023)

Current Status on Therapeutic Molecules Targeting Siglec Receptors
por: Lenza, María Pia, et al.
Publicado: (2020)

Small Molecules from Nature Targeting G-Protein Coupled Cannabinoid Receptors: Potential Leads for Drug Discovery and Development
por: Sharma, Charu, et al.
Publicado: (2015)

Structure-Based Identification of Potent Natural Product Chemotypes as Cannabinoid Receptor 1 Inverse Agonists
por: Pandey, Pankaj, et al.
Publicado: (2018)

Current status, challenges and prospects for dairy goat production in the Americas
por: Lu, Christopher D., et al.
Publicado: (2019)

Cannabinoid interactions with ion channels and receptors
por: Watkins, Abeline Rose
Publicado: (2019)

Molecular Insights into Epigenetics and Cannabinoid Receptors
por: Basavarajappa, Balapal S., et al.
Publicado: (2022)

Novel Theranostic Approaches Targeting CCR4-Receptor, Current Status and Translational Prospectives: A Systematic Review
por: Gorica, Joana, et al.
Publicado: (2023)

New Prospect for Cancer Cachexia: Medical Cannabinoid
por: Wang, Jing, et al.
Publicado: (2019)

Design of New Potent and Selective Thiophene-Based K(V)1.3 Inhibitors and Their Potential for Anticancer Activity
por: Gubič, Špela, et al.
Publicado: (2022)

Correction: Gubič et al. Design of New Potent and Selective Thiophene-Based K(V)1.3 Inhibitors and Their Potential for Anticancer Activity. Cancers 2022, 14, 2595
por: Gubič, Špela, et al.
Publicado: (2023)

Machine learning in TCM with natural products and molecules: current status and future perspectives
por: Ma, Suya, et al.
Publicado: (2023)

Targeting COPD with PLGA-Based Nanoparticles: Current Status and Prospects
por: Saxena, Juhi, et al.
Publicado: (2022)

Emerging drugs of abuse: current perspectives on synthetic cannabinoids
por: Debruyne, Danièle, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9fib9ruddi3ipek0sjj5nq559i